COLGATE-PALMOLIVE CO (CL) Forecast, Price Target & Analyst Ratings
NYSE:CL • US1941621039
92.49 USD
-0.51 (-0.55%)
At close: Mar 10, 2026
92.49 USD
0 (0%)
After Hours: 3/10/2026, 8:14:26 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COLGATE-PALMOLIVE CO (CL).
Forecast Snapshot
Consensus Price Target
$97.50
+ 5.41% Upside
Next Earnings Forecast
Release DateMay 1, 2026
PeriodQ1 / 2026
EPS Estimate$0.97
Revenue Estimate5.363B
ChartMill Buy Consensus
74.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$97.50
Upside
+ 5.41%
From current price of $92.49 to mean target of $97.50, Based on 30 analyst forecasts
Low
$75.75
Median
$97.92
High
$110.25
Price Target Revisions
1 Month
1.38%
3 Months
9.77%
Price Target Summary
30 Wall Street analysts provided a forecast for the next 12 months for CL. The average price target is 97.5 USD. This implies a price increase of 5.41% is expected in the next year compared to the current price of 92.49.
The average price target has been revised upward by 9.77% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
74.67%
CL was analyzed by 30 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CL.
In the previous month the buy percentage consensus was at a similar level.
CL was analyzed by 30 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | Deutsche Bank | Maintains | Hold -> Hold |
| 2026-02-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-02 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-02 | B of A Securities | Maintains | Buy -> Buy |
| 2026-02-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-02-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-02 | Citigroup | Maintains | Buy -> Buy |
| 2026-02-02 | Jefferies | Maintains | Hold -> Hold |
| 2026-01-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-14 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2026-01-08 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-11 | Argus Research | Downgrade | Buy -> Hold |
| 2025-12-09 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2025-11-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-03 | UBS | Maintains | Buy -> Buy |
| 2025-11-03 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-11-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-03 | Citigroup | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 1, 2026
PeriodQ1 / 2026
EPS Estimate$0.97
Revenue Estimate5.363B
Revenue Q2Q9.20%
EPS Q2Q7.00%
Number of Analysts19
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
1.23%
EPS (1 Month)
-0.33%
EPS (3 Months)
0.00%
Next Earnings Summary
CL is expected to report earnings on 5/1/2026. The consensus EPS estimate for the next earnings is 0.97 USD and the consensus revenue estimate is 5.36B USD.
The next earnings revenue estimate has been revised upward by 1.23% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.457B 8.29% | 20.101B 3.31% | 20.382B 1.40% | 21.93B 7.59% | 22.655B 3.31% | 23.488B 3.68% | 23.944B 1.94% | 24.789B 3.53% | 25.319B 2.14% | 26.309B 3.91% | 27.336B 3.90% | |
| EBITDA YoY % growth | 4.585B 8.80% | 4.916B 7.22% | 4.956B 0.81% | 5.304B 7.02% | 5.546B 4.56% | 5.841B 5.32% | 6.081B 4.11% | 6.346B 4.36% | 6.848B 7.91% | 7.17B 4.70% | 7.504B 4.66% | |
| EBIT YoY % growth | 4.018B 9.51% | 4.311B 7.29% | 4.326B 0.35% | 4.645B 7.37% | 4.873B 4.91% | 5.144B 5.56% | 5.389B 4.76% | 5.64B 4.66% | 6.049B 7.25% | 6.341B 4.83% | 6.645B 4.79% | |
| Operating Margin | 20.65% | 21.45% | 21.22% | 21.18% | 21.51% | 21.90% | 22.51% | 22.75% | 23.89% | 24.10% | 24.31% | |
| EPS YoY % growth | 3.23 8.75% | 3.59 11.15% | 3.69 2.79% | 4.00 8.32% | 4.27 6.85% | 4.58 7.20% | 4.85 5.88% | 5.15 6.25% | 5.74 11.41% | 6.15 7.18% | 6.59 7.20% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.97 7.00% | 1.00 8.35% | 0.98 7.96% | 1.00 4.95% | 1.04 6.79% | 1.06 6.79% | 1.04 6.29% | 1.06 6.28% |
| Revenue Q2Q % growth | 5.363B 9.20% | 5.491B 7.46% | 5.438B 5.98% | 5.428B 3.79% | 5.495B 2.46% | 5.62B 2.35% | 5.627B 3.48% | 5.615B 3.45% |
| EBITDA Q2Q % growth | 1.304B 5.25% | 1.324B -4.61% | 1.307B -13.79% | 1.319B -24.11% | 1.358B 4.14% | 1.389B 4.91% | 1.353B 3.52% | 1.376B 4.32% |
| EBIT Q2Q % growth | 1.145B 4.95% | 1.158B 6.34% | 1.148B 8.40% | 1.162B 4.87% | 1.2B 4.80% | 1.228B 6.04% | 1.203B 4.79% | 1.225B 5.42% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.45%
EPS Next 5 Year
6.89%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.00%
Revenue Next 5 Year
3.49%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
9.49%
EBIT Next 5 Year
7.36%
COLGATE-PALMOLIVE CO / CL Forecast FAQ
Can you provide the average price target for COLGATE-PALMOLIVE CO stock?
30 analysts have analysed CL and the average price target is 97.5 USD. This implies a price increase of 5.41% is expected in the next year compared to the current price of 92.49.
Can you provide the upcoming earnings date for COLGATE-PALMOLIVE CO?
COLGATE-PALMOLIVE CO (CL) will report earnings on 2026-05-01, before the market open.
What are the consensus estimates for COLGATE-PALMOLIVE CO (CL) next earnings?
The consensus EPS estimate for the next earnings of COLGATE-PALMOLIVE CO (CL) is 0.97 USD and the consensus revenue estimate is 5.36B USD.
How many analysts have analysed COLGATE-PALMOLIVE CO (CL)?
The number of analysts covering COLGATE-PALMOLIVE CO (CL) is 30.